The trademark application STRYNUVA was filed by Millennium Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 26, 2014, and it was registered by office on September 2, 2014 without any oppositions.
The application was filed in English (German was selected as the second language).
The renewal of the trademark was recorded by the office on February 5, 2024.
Appointment and Replacement of representative of the trademark registration was recorded on June 16, 2020.